To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department of Radiation ...
Despite the prevalence of cancer misinformation, exposure to it is not associated with greater fear of cancer recurrence or ...
Mayo Clinic's Department of Radiation Oncology has launched the PSA Control Tower, an innovative tool designed to enhance the ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Weinstein brings more than two decades of experience in life sciences leadership, venture capital, and company buildingProven track record of guiding innovative healthcare organizations from ...
About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...
The nutritional value of powdered flax seeds stems from their omega-3 fats, fiber content and lignans, which enable people to ...
NovaUCD-based medtech OncoAssure has signed a research collaboration agreement with the Icahn School of Medicine at Mount ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback